2-Hydroxypropyl-β-cyclodextrin accesses acute and subacute infarcts in a mouse model of ischemic stroke

Key Points

• Acute and subacute infarcts were accessed by 2-hydroxypropyl-beta-cyclodextrin in the model.
• The intervention showed success in addressing area restoration in stroke-damaged regions.
• Analysis involved an experimental mouse model, examining the pharmacological effects of the compound.
• Animal model; further preclinical work needed to validate efficacy in humans.